196 related articles for article (PubMed ID: 32492856)
1. Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures.
Braun LM; Lagies S; Klar RFU; Hussung S; Fritsch RM; Kammerer B; Wittel UA
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492856
[TBL] [Abstract][Full Text] [Related]
2. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer.
Grossman JE; Muthuswamy L; Huang L; Akshinthala D; Perea S; Gonzalez RS; Tsai LL; Cohen J; Bockorny B; Bullock AJ; Schlechter B; Peters MLB; Conahan C; Narasimhan S; Lim C; Davis RB; Besaw R; Sawhney MS; Pleskow D; Berzin TM; Smith M; Kent TS; Callery M; Muthuswamy SK; Hidalgo M
Clin Cancer Res; 2022 Feb; 28(4):708-718. PubMed ID: 34789479
[TBL] [Abstract][Full Text] [Related]
3. Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.
Gao M; Harper MM; Lin M; Qasem SA; Patel RA; Mardini SH; Gabr MM; Cavnar MJ; Pandalai PK; Kim J
J Am Coll Surg; 2021 Apr; 232(4):504-514. PubMed ID: 33253861
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.
Seppälä TT; Zimmerman JW; Sereni E; Plenker D; Suri R; Rozich N; Blair A; Thomas DL; Teinor J; Javed A; Patel H; Cameron JL; Burns WR; He J; Tuveson DA; Jaffee EM; Eshleman J; Szabolcs A; Ryan DP; Ting DT; Wolfgang CL; Burkhart RA
Ann Surg; 2020 Sep; 272(3):427-435. PubMed ID: 32657929
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine.
Frappart PO; Hofmann TG
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987786
[TBL] [Abstract][Full Text] [Related]
6. Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids.
Naumann M; Czempiel T; Lößner AJ; Pape K; Beyreuther E; Löck S; Drukewitz S; Hennig A; von Neubeck C; Klink B; Krause M; William D; Stange DE; Bütof R; Dietrich A
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954444
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy.
Choi D; Gonzalez-Suarez AM; Dumbrava MG; Medlyn M; de Hoyos-Vega JM; Cichocki F; Miller JS; Ding L; Zhu M; Stybayeva G; Gaspar-Maia A; Billadeau DD; Ma WW; Revzin A
Adv Sci (Weinh); 2024 Feb; 11(5):e2303088. PubMed ID: 38018486
[TBL] [Abstract][Full Text] [Related]
8. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study.
Nicosia L; Alongi F; Andreani S; Ruggieri R; Rusev B; Mantoan B; Lawlor RT; Pea A; Scarpa A; Agolli L; Corbo V; D'Agosto S
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33327494
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of parathyroid organoids.
Sekhar KR; Codreanu SG; Williams OC; Rathmell JC; Rathmell WK; McLean JA; Sherrod SD; Baregamian N
Front Endocrinol (Lausanne); 2023; 14():1223312. PubMed ID: 37492197
[TBL] [Abstract][Full Text] [Related]
11. Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models.
Tiriac H; French R; Lowy AM
J Vis Exp; 2020 Jan; (155):. PubMed ID: 32009658
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
Demyan L; Habowski AN; Plenker D; King DA; Standring OJ; Tsang C; St Surin L; Rishi A; Crawford JM; Boyd J; Pasha SA; Patel H; Galluzzo Z; Metz C; Gregersen PK; Fox S; Valente C; Abadali S; Matadial-Ragoo S; DePeralta DK; Deutsch GB; Herman JM; Talamini MA; Tuveson DA; Weiss MJ
Ann Surg; 2022 Sep; 276(3):450-462. PubMed ID: 35972511
[TBL] [Abstract][Full Text] [Related]
13. Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.
Lin X; Zhan B; Wen S; Li Z; Huang H; Feng J
Mol Biosyst; 2016 Aug; 12(9):2883-92. PubMed ID: 27400832
[TBL] [Abstract][Full Text] [Related]
14. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
[TBL] [Abstract][Full Text] [Related]
15. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
16. The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids.
Low RRJ; Lim WW; Nguyen PM; Lee B; Christie M; Burgess AW; Gibbs P; Grimmond SM; Hollande F; Putoczki TL
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638463
[TBL] [Abstract][Full Text] [Related]
17. Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota.
Perelló-Reus CM; Rubio-Tomás T; Cisneros-Barroso E; Ibargüen-González L; Segura-Sampedro JJ; Morales-Soriano R; Barceló C
Front Oncol; 2022; 12():995357. PubMed ID: 36531066
[TBL] [Abstract][Full Text] [Related]
18. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
19. Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics.
Lindahl A; Heuchel R; Forshed J; Lehtiö J; Löhr M; Nordström A
Metabolomics; 2017; 13(5):61. PubMed ID: 28413374
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
